Epitalon 50 mg: Advanced Telomere Support for Cellular Longevity Research Dragon Pharma introduces Epitalon 50 mg, a groundbreaking peptide that represents the cutting edge of anti-aging and cellular longevity research. This synthetic tetrapeptide, designed to mimic the natural epithalamin peptide produced by the pineal gland, offers unprecedented opportunities for studying telomere maintenance, cellular senescence, and age-related physiological decline. With third-party laboratory verification confirming 51.46 mg actual content per vial, researchers can trust the precision and quality of Dragon Pharma’s formulation. Epitalon’s unique ability to influence gene expression related to aging makes it particularly valuable for comprehensive longevity and performance optimization…
Author: dragon
GLOW 60 mg: The Ultimate Healing Peptide Synergy for Comprehensive Tissue Regeneration Dragon Pharma introduces GLOW 60 mg, a revolutionary peptide blend that represents the pinnacle of regenerative medicine research. This sophisticated combination brings together three of the most powerful healing compounds—BPC-157, TB-500, and GHK-Cu—in one optimized formulation. Designed for researchers seeking maximum recovery potential, GLOW addresses tissue repair from multiple angles: accelerating wound healing, reducing inflammation, promoting angiogenesis, and stimulating collagen production. For bodybuilders and athletes, this comprehensive blend offers unprecedented research opportunities in injury recovery, joint health optimization, and overall tissue resilience during intense training cycles. DRUG DESCRIPTION…
Tirzepatide 10 mg: Advanced Dual Incretin Agonist for Metabolic Research Dragon Pharma introduces Tirzepatide 10 mg, a cutting-edge dual incretin agonist that represents a significant advancement in metabolic research and weight management science. This innovative compound simultaneously activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a powerful synergistic approach to studying metabolic regulation. With third-party laboratory verification confirming 9.94 mg actual content per vial, researchers can trust the precision and quality of Dragon Pharma’s formulation. Tirzepatide’s dual-mechanism action offers comprehensive research opportunities in appetite control, glucose metabolism, and body composition optimization through complementary incretin receptor activation.…
GHRP-6 10 mg: Potent Growth Hormone Secretagogue for Muscle Growth and Recovery Dragon Pharma presents GHRP-6 10 mg, a powerful growth hormone-releasing peptide that has become a cornerstone of modern performance enhancement research. As one of the most effective secretagogues in its class, GHRP-6 (Growth Hormone Releasing Peptide-6) stimulates the pituitary gland to produce and release significant amounts of endogenous growth hormone. For bodybuilders and athletes, this translates to research opportunities in accelerated muscle growth, enhanced fat loss, improved recovery capacity, and increased appetite—making it particularly valuable for mass-gaining phases. Dragon Pharma’s high-purity formulation ensures researchers have access to a…
Thymosin Alpha-1 10 mg: Advanced Immune System Modulation for Optimal Performance Dragon Pharma introduces Thymosin Alpha-1 10 mg, a sophisticated immune-modulating peptide that represents a breakthrough in performance optimization and recovery research. This naturally occurring thymic peptide plays a crucial role in regulating immune function, reducing excessive inflammation, and supporting overall immune system balance. For bodybuilders and athletes constantly pushing their physical limits, Dragon Pharma Thymosin Alpha-1 offers unprecedented research opportunities in immune support, inflammation management, and recovery enhancement. Its ability to modulate rather than suppress immune responses makes it particularly valuable for studying optimal immune function during periods of…
GHK-cu 50 mg: High-Potency Copper Peptide for Advanced Regenerative Research Dragon Pharma elevates regenerative research with its high-potency GHK-cu 50 mg formulation. This concentrated copper peptide delivers five times the active substance of the standard 10 mg version, providing researchers with a powerful tool for advanced tissue repair and systemic rejuvenation studies. The increased concentration makes it particularly valuable for protocols requiring significant dosing, topical formulations, or research into more challenging regenerative scenarios. For bodybuilders and athletes, this high-strength version enables more comprehensive studies on accelerated recovery from intense training, surgical wounds, and advanced skin remodeling. DRUG DESCRIPTION Dragon Pharma’s…
TB 500 5 mg/BPC 157 5 mg: The Ultimate Healing Peptide Synergy for Comprehensive Tissue Repair Dragon Pharma presents the TB 500/BPC 157 combination, a revolutionary peptide stack that represents the pinnacle of tissue repair and recovery research. This expertly formulated blend combines two of the most powerful healing peptides in a single vial, creating unprecedented synergistic effects for studying injury recovery, inflammation reduction, and tissue regeneration. With third-party laboratory verification confirming 5.43 mg TB 500 and 4.95 mg BPC 157 actual content, researchers can trust the precision and quality of Dragon Pharma’s formulation. This combination offers comprehensive research opportunities…
GHK-cu 10 mg: The Revolutionary Copper Peptide for Skin and Tissue Regeneration Dragon Pharma presents GHK-cu 10 mg, a groundbreaking copper-binding peptide that has revolutionized research in tissue repair and skin rejuvenation. This unique tripeptide (glycyl-l-histidyl-l-lysine) complexed with copper has demonstrated remarkable abilities to promote wound healing, enhance collagen production, and exert powerful antioxidant effects. For bodybuilders and fitness enthusiasts, GHK-cu offers a sophisticated research tool for accelerating recovery from intense training, improving skin quality, and supporting overall tissue health. Its multifaceted regenerative properties make it a valuable asset in any comprehensive performance and wellness research protocol. DRUG DESCRIPTION Dragon…
Survodutide 10 mg: Advanced Dual Agonist for Metabolic Optimization Research Dragon Pharma introduces Survodutide 10 mg, a sophisticated dual agonist peptide that represents the next generation of metabolic research compounds. This innovative molecule simultaneously activates both glucagon-like peptide-1 (GLP-1) and glucagon receptors, creating a powerful synergistic approach to studying weight management, metabolic syndrome, and body composition optimization. With third-party laboratory verification confirming 9.68 mg actual content per vial, researchers can trust the precision and reliability of Dragon Pharma’s formulation. Survodutide’s balanced dual-mechanism action offers comprehensive research opportunities in appetite control, energy expenditure enhancement, and metabolic health improvement through complementary receptor…
DSIP 10 mg: The Ultimate Peptide for Sleep Optimization and Recovery Dragon Pharma introduces DSIP 10 mg, a specialized neuropeptide dedicated to one of the most crucial yet often overlooked aspects of athletic performance: sleep quality. Delta Sleep Inducing Peptide (DSIP) represents a sophisticated approach to enhancing natural sleep architecture, particularly deep delta wave sleep. For bodybuilders and fitness enthusiasts, optimal sleep is not merely about rest—it’s when the body releases Growth Hormone, repairs muscle tissue, and regulates crucial hormones. Dragon Pharma DSIP offers researchers a targeted tool to study how enhancing sleep quality can directly translate to improved recovery,…